BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4367918)

  • 1. A comparative study of two structurally related analogs of Asp1-Ile5-angiotensin II.
    Türker RK; Gündoğan NU
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(4):411-20. PubMed ID: 4367918
    [No Abstract]   [Full Text] [Related]  

  • 2. A potent competitive antagonist of angiotensin II.
    Yamamoto M; Türker RK; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1972 May; 18(3):316-22. PubMed ID: 4338477
    [No Abstract]   [Full Text] [Related]  

  • 3. Synthesis of angiotensin II antagonists containing N- and O-methylated and other amino acid residues.
    Khosla MC; Mũnoz-Ramírez H; Hall MM; Smeby RR; Khairallah PA; Bumpus FM; Peach MJ
    J Med Chem; 1976 Feb; 19(2):244-50. PubMed ID: 2777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin analogs: the influence of sarcosine substituted in position 1.
    Hall MM; Khosla MC; Khairallah PA; Bumpus FM
    J Pharmacol Exp Ther; 1974 Jan; 188(1):222-8. PubMed ID: 4358436
    [No Abstract]   [Full Text] [Related]  

  • 5. New specific angiotensin antagonists. (8-Valine)-, (8-isoleucine)-, and chlorambucil-des-1-aspartic,8-valine-angiotensins I.
    Paiva AC; Nouaihetas VL; Miyamoto ME; Mendes GB; Paiva TB
    J Med Chem; 1973 Jan; 16(1):6-9. PubMed ID: 4344926
    [No Abstract]   [Full Text] [Related]  

  • 6. A new short-acting antagonist of angiotensin II.
    Türker RK; Yamamoto M; Bumpus FM
    Arch Int Pharmacodyn Ther; 1973 Jan; 201(1):162-9. PubMed ID: 4352152
    [No Abstract]   [Full Text] [Related]  

  • 7. A new, long-lasting competitive inhibitor of angiotensin.
    Türker RK; Hall MM; Yamamoto M; Sweet CS; Bumpus FM
    Science; 1972 Sep; 177(4055):1203-5. PubMed ID: 4341570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of analogs of (8-isoleucine)angiotensin II with variations in position 1.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Apr; 17(4):431-3. PubMed ID: 4364509
    [No Abstract]   [Full Text] [Related]  

  • 9. Competitive inhibition of Asp1-beta-amide-Val5-angiotensin II by Sar1-Ile5-Ile8-angiotensin II in cat isolated cardiac muscle and coronary vessels.
    Türker RK; Hall MM; Bumpus FM
    J Pharm Pharmacol; 1974 Aug; 26(8):582-7. PubMed ID: 4155722
    [No Abstract]   [Full Text] [Related]  

  • 10. Solid-phase synthesis of (6-arginine)-, (4-histidine, 6-tyrosine)-, and (8-isoleucine)angiotensins II.
    Khosla MC; Kumar S; Smeby RR; Bumpus FM
    J Med Chem; 1972 Jun; 15(6):627-9. PubMed ID: 4337901
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of the N-terminal amino acid for the biological activities of angiotensin and inhibitory analogues.
    Regoli D; Rioux F; Park WK; Choi C
    Can J Physiol Pharmacol; 1974 Feb; 52(1):39-49. PubMed ID: 4363494
    [No Abstract]   [Full Text] [Related]  

  • 12. Change of activity in rabbit aorta of three analogs of angiotensin substituted in nh2-terminal position.
    Türker RK; Ercan ZS
    Pharmacology; 1975; 13(2):155-62. PubMed ID: 1144515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,8-disubstituted analogues of (Ile5) and (Val5)angiotensin II: difference in potency and specificity of angiotensin II-antagonistic activity.
    Schoelkens BA; Wissmann H; Lindner E; Geiger R
    Hoppe Seylers Z Physiol Chem; 1976 Jun; 357(6):825-38. PubMed ID: 955577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo studies of (1-sarcosine, 8-threonine) angiotensin II.
    Muñoz-Ramírez H; Khosla MC; Hall MM; Bumpus FM; Khairallah PA
    Res Commun Chem Pathol Pharmacol; 1976 Apr; 13(4):649-63. PubMed ID: 4864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. II. Pharmacology of angiotensin antagonists.
    Regoli D; Park WK; Rioux F
    Can J Physiol Pharmacol; 1973 Feb; 51(2):114-21. PubMed ID: 4348959
    [No Abstract]   [Full Text] [Related]  

  • 16. Agonist and antagonist relationships in 1- and 8-substituted analogs of angiotensin II.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1974 Nov; 17(11):1156-60. PubMed ID: 4369767
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin antagonists and the adrenal cortex and medulla.
    Peach MJ; Ackerly JA
    Fed Proc; 1976 Nov; 35(13):2502-7. PubMed ID: 976492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of smooth muscle receptors for angiotensin: studies with an antagonist.
    Mimran A; Hinrichs KJ; Hollenberg NK
    Am J Physiol; 1974 Jan; 226(1):185-90. PubMed ID: 4358849
    [No Abstract]   [Full Text] [Related]  

  • 19. Solid-phase synthesis of (3-proline,8-isoleucine)-,(1-sarcosine,3-proline,8-isoleucine)-, and (4-phenylalanine,8-isoleucine)angiotensin II as the antagonists of the parent hormone.
    Khosla MC; Hall MM; Smeby RR; Bumpus FM
    J Med Chem; 1973 Oct; 16(10):1184-5. PubMed ID: 4356140
    [No Abstract]   [Full Text] [Related]  

  • 20. Angiotensin-catecholamine interactions in the rabbit.
    Peach MJ; Cline WH; Davila D; Khairallah PA
    Eur J Pharmacol; 1970; 11(3):286-92. PubMed ID: 4320089
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.